Phase 1 Lupus Erythematosus, Systemic Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Lupus Erythematosus, Systemic
AstraZeneca150 enrolled16 locationsNCT06897930
Recruiting
Phase 1
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
SLE (Systemic Lupus)Diffuse Cutaneous Systemic SclerosisSystemic Sclerosis+4 more
CRISPR Therapeutics80 enrolled8 locationsNCT06925542
Recruiting
Phase 1
Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Chinese SLE Treatment And Research Group20 enrolled1 locationNCT06881290
Recruiting
Phase 1Phase 2
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases
Lupus Erythematosus, SystemicSystem; Sclerosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS8 enrolled1 locationNCT06685042